Literature DB >> 11728952

Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1.

A Lumiaho1, R Ikäheimo, R Miettinen, L Niemitukia, T Laitinen, A Rantala, E Lampainen, M Laakso, J Hartikainen.   

Abstract

Patients with autosomal dominant polycystic kidney disease (ADPKD) have an increased occurrence of cardiac valve abnormalities. However, the prevalence of cardiac abnormalities in patients with a uniform genotype of ADPKD has not been previously reported. We performed M-mode and color Doppler echocardiography on 109 patients from 16 families with polycystic kidney disease type 1 (PKD1). Findings were compared with those of 73 unaffected family members and 73 healthy controls. Mitral valve prolapse was found in 26% of patients with PKD1, 14% of unaffected relatives, and 10% of control subjects. The prevalence of hemodynamically significant mitral regurgitation (grade 2 or 3) was 13%, 4%, and 3%, respectively. Prevalences of grade 2 or 3 aortic regurgitation (8%, 4%, and 3%, respectively) and tricuspid regurgitation (4%, 6%, and 7%, respectively) were not significantly different among the three groups. Left ventricular hypertrophy (LVH) was found in 19% of subjects with PKD1, 6% of unaffected relatives, and 4% of control subjects. Systolic blood pressure and severity of renal insufficiency were related to mitral regurgitation and LVH in subjects with PKD1. The prevalence of cardiac valve abnormalities did not differ between unaffected relatives and control subjects. Mitral valve prolapse is a characteristic finding in patients with PKD1. Conversely, mitral regurgitation and LVH are likely to be secondary to elevated blood pressure in these patients.

Entities:  

Mesh:

Year:  2001        PMID: 11728952     DOI: 10.1053/ajkd.2001.29216

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  26 in total

Review 1.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

2.  Primary cilia defects causing mitral valve prolapse.

Authors:  Katelynn A Toomer; Mengyao Yu; Diana Fulmer; Lilong Guo; Kelsey S Moore; Reece Moore; Ka'la D Drayton; Janiece Glover; Neal Peterson; Sandra Ramos-Ortiz; Alex Drohan; Breiona J Catching; Rebecca Stairley; Andy Wessels; Joshua H Lipschutz; Francesca N Delling; Xavier Jeunemaitre; Christian Dina; Ryan L Collins; Harrison Brand; Michael E Talkowski; Federica Del Monte; Rupak Mukherjee; Alexander Awgulewitsch; Simon Body; Gary Hardiman; E Starr Hazard; Willian A da Silveira; Baolin Wang; Maire Leyne; Ronen Durst; Roger R Markwald; Solena Le Scouarnec; Albert Hagege; Thierry Le Tourneau; Peter Kohl; Eva A Rog-Zielinska; Patrick T Ellinor; Robert A Levine; David J Milan; Jean-Jacques Schott; Nabila Bouatia-Naji; Susan A Slaugenhaupt; Russell A Norris
Journal:  Sci Transl Med       Date:  2019-05-22       Impact factor: 17.956

Review 3.  Hypertension in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; Konrad Stepniakowski; Frederic Rahbari-Oskoui
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

4.  Genetics and phenotypic characteristics of autosomal dominant polycystic kidney disease in Finns.

Authors:  Paula Peltola; Anne Lumiaho; Raija Miettinen; Jussi Pihlajamäki; Richard Sandford; Markku Laakso
Journal:  J Mol Med (Berl)       Date:  2005-03-17       Impact factor: 4.599

5.  Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring.

Authors:  Maria V Irazabal; Prasanna K Mishra; Vicente E Torres; Slobodan I Macura
Journal:  J Vis Exp       Date:  2015-06-23       Impact factor: 1.355

6.  A role for primary cilia in aortic valve development and disease.

Authors:  Katelynn A Toomer; Diana Fulmer; Lilong Guo; Alex Drohan; Neal Peterson; Paige Swanson; Brittany Brooks; Rupak Mukherjee; Simon Body; Joshua H Lipschutz; Andy Wessels; Russell A Norris
Journal:  Dev Dyn       Date:  2017-06-28       Impact factor: 3.780

Review 7.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

8.  Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy.

Authors:  Jere Paavola; Simon Schliffke; Sandro Rossetti; Ivana Y-T Kuo; Shiaulou Yuan; Zhaoxia Sun; Peter C Harris; Vicente E Torres; Barbara E Ehrlich
Journal:  J Mol Cell Cardiol       Date:  2013-01-30       Impact factor: 5.000

Review 9.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

10.  Multiple cardiovascular manifestations in a patient with autosomal dominant polycystic kidney disease.

Authors:  Young Ran Kang; Jong-Hwa Ahn; Kye Hwan Kim; Young Min Choi; Jungwoo Choi; Jeong Rang Park
Journal:  J Cardiovasc Ultrasound       Date:  2014-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.